SOFTBONE - Soft bone cement for better treatment of osteoporotic fractures


The goal of the EIT Health project SOFTBONE is to provide a way to treat spinal fractures in osteoporotic patients that can reduce the re-hospitalization rate and associated costs.

In 2020, the estimated number of treatments worldwide where bone cement is injected into osteoporotic vertebral fractures is 1.4 million/year. The market is growing due to the increased occurence of osteoporosis - the part of the population in Europe over 65 years old with osteoporosis is expected to be doubled in 2050. 

Osteoporosis is a large problem globally with our ageing population. Approx. 1 in 2 women and 1 in 4 men over 50 years old are affected and may suffer a fracture due to the weakened bone. Fractures in the spine are common and can be treated by injecting bone cement into the vertebral body, stabilizing the fracture and providing pain-relief. However, the bone cements that are currently used to treat the vertebrae are too stiff for the surrounding osteoporotic bone, causing new fractures in up to 40% of the patients.


The SOFTBONE project aims to decrease this number from 40% to 5%, through the use of a novel, softer, patented bone cement formulation.

Click here to Contact us